scholarly article | Q13442814 |
P50 | author | Helmut Friess | Q15453363 |
Katja Steiger | Q52699946 | ||
Jorg Kleeff | Q57039562 | ||
Güralp O Ceyhan | Q89090011 | ||
Karin Kleigrewe | Q90574788 | ||
Shanshan Shen | Q96585039 | ||
Christoph W Michalski | Q114441105 | ||
Ziying Jian | Q117231801 | ||
Susanne Raulefs | Q117231802 | ||
Nadja Maeritz | Q117231803 | ||
P2093 | author name string | Bo Kong | |
Martin Jastroch | |||
Tao Cheng | |||
Thomas Hofmann | |||
Xiaoping Zou | |||
Kuangyu Shi | |||
Carsten Jäger | |||
Peilin Huang | |||
Philipp Bruns | |||
Zhiheng Zhang | |||
Daniel Lamp | |||
Shuang Nie | |||
Simone Benitz | |||
Jan Akkan | |||
P2860 | cites work | Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells | Q24648994 |
DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer. | Q27851466 | ||
Expression of HOXB2, a retinoic acid signaling target in pancreatic cancer and pancreatic intraepithelial neoplasia | Q28248216 | ||
Interplay between epigenetics and metabolism in oncogenesis: mechanisms and therapeutic approaches | Q33835913 | ||
Comparative epigenomics of human and mouse mammary tumors. | Q34089646 | ||
Diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium. | Q34250010 | ||
Antidiabetic therapies affect risk of pancreatic cancer | Q34976430 | ||
Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein | Q35046706 | ||
Impact of preoperative diabetes on long-term survival after curative resection of pancreatic adenocarcinoma: a systematic review and meta-analysis | Q35063344 | ||
Upstream and downstream targets of RUNX proteins. | Q35102286 | ||
RUNX3 Controls a Metastatic Switch in Pancreatic Ductal Adenocarcinoma | Q35690596 | ||
Glucose Uptake and Runx2 Synergize to Orchestrate Osteoblast Differentiation and Bone Formation | Q35762267 | ||
Impact of diabetes mellitus on clinical outcomes in patients undergoing surgical resection for pancreatic cancer: a retrospective, cohort study. | Q35771246 | ||
Metformin use is associated with better survival of diabetic patients with pancreatic cancer | Q36053323 | ||
Hypoxia-induced endoplasmic reticulum stress characterizes a necrotic phenotype of pancreatic cancer | Q36544797 | ||
Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus. | Q36571182 | ||
Impact of Metformin on Advanced Pancreatic Cancer Survival: Too Little, Too Late? | Q36642870 | ||
RAR and RXR modulation in cancer and metabolic disease | Q36956230 | ||
Metformin Improves Survival in Patients with Pancreatic Ductal Adenocarcinoma and Pre-Existing Diabetes: A Propensity Score Analysis | Q37294190 | ||
Cancer cell survival during detachment from the ECM: multiple barriers to tumour progression | Q38237431 | ||
Use of antidiabetic agents and the risk of pancreatic cancer: a case-control analysis. | Q38434723 | ||
A Continuously Infused Microfluidic Radioassay System for the Characterization of Cellular Pharmacokinetics | Q38760641 | ||
Limited heterogeneity of known driver gene mutations among the metastases of individual patients with pancreatic cancer | Q38769887 | ||
Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver | Q38873616 | ||
Metformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trial | Q38996447 | ||
Cancer Statistics, 2017. | Q39038674 | ||
A Clinical Prediction Model to Assess Risk for Pancreatic Cancer Among Patients With New-Onset Diabetes | Q39126045 | ||
Dynamic landscape of pancreatic carcinogenesis reveals early molecular networks of malignancy | Q39372879 | ||
The impact of diabetes mellitus on survival following resection and adjuvant chemotherapy for pancreatic cancer | Q39432270 | ||
In vivo functional dissection of a context-dependent role for Hif1α in pancreatic tumorigenesis | Q39678707 | ||
Metformin Use Is Associated with Improved Survival in Patients Undergoing Resection for Pancreatic Cancer | Q39714372 | ||
Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancer | Q39800540 | ||
Regulation of AML2/CBFA3 in hematopoietic cells through the retinoic acid receptor alpha-dependent signaling pathway | Q40939844 | ||
Polycomb repressor complex 1 promotes gene silencing through H2AK119 mono-ubiquitination in acinar-to-ductal metaplasia and pancreatic cancer cells | Q42729081 | ||
Epigenomic reprogramming during pancreatic cancer progression links anabolic glucose metabolism to distant metastasis | Q47106431 | ||
Direct Substrate Delivery Into Mitochondrial Fission-Deficient Pancreatic Islets Rescues Insulin Secretion | Q47979591 | ||
Mutant p53 Together with TGFβ Signaling Influence Organ-Specific Hematogenous Colonization Patterns of Pancreatic Cancer. | Q52848530 | ||
A subset of metastatic pancreatic ductal adenocarcinomas depends quantitatively on oncogenic Kras/Mek/Erk-induced hyperactive mTOR signalling. | Q53224745 | ||
(Ir)relevance of Metformin Treatment in Patients with Metastatic Pancreatic Cancer: An Open-Label, Randomized Phase II Trial. | Q53314142 | ||
Measurement of Glucose Uptake in Cultured Cells | Q86870920 | ||
Reduced retinoids and retinoid receptors' expression in pancreatic cancer: A link to patient survival | Q87676296 | ||
P433 | issue | 4 | |
P921 | main subject | invasive ductal carcinoma | Q1671685 |
pancreatic ductal carcinoma | Q8263002 | ||
pancreatic ductal adenocarcinoma | Q18555956 | ||
P304 | page(s) | 429-449 | |
P577 | publication date | 2018-07-26 | |
P1433 | published in | Cellular and molecular gastroenterology and hepatology | Q27726289 |
P1476 | title | Glycemic Variability Promotes Both Local Invasion and Metastatic Colonization by Pancreatic Ductal Adenocarcinoma | |
P478 | volume | 6 |
Q91574559 | COL6A1 promotes metastasis and predicts poor prognosis in patients with pancreatic cancer |
Q90382725 | Glucose Metabolism in Pancreatic Cancer |
Q90226833 | Hyperglycemia Associated Metabolic and Molecular Alterations in Cancer Risk, Progression, Treatment, and Mortality |
Q64902344 | RUNX family: Oncogenes or tumor suppressors (Review). |
Search more.